Based on the correlations between the driver gene (NF1, BRAF, and RAS) alterations and clinical characterizations (ulceration, lymph node metastasis), patients harboring more mutations were prone to poor prognosis. The gene discussed is BRAF; the disease is metastatic malignant neoplasm in the lymph nodes.